Your browser doesn't support javascript.
loading
Invited letter in response to "Predicted indirectly recognizable HLA epitopes (PIRCHE): Only the tip of the iceberg?"
Lachmann, Nils; Niemann, Matthias; Reinke, Petra; Budde, Klemens; Schmidt, Danilo; Halleck, Fabian; Pruß, Axel; Schönemann, Constanze; Spierings, Eric; Staeck, Oliver.
Affiliation
  • Lachmann N; Center for Tumor Medicine, H&I Laboratory, Charité University Medicine Berlin, Berlin, Germany.
  • Niemann M; PIRCHE AG, Berlin, Germany.
  • Reinke P; Department of Nephrology, Charité University Medicine Berlin, Berlin, Germany.
  • Budde K; Department of Nephrology, Charité University Medicine Berlin, Berlin, Germany.
  • Schmidt D; Department of Nephrology, Charité University Medicine Berlin, Berlin, Germany.
  • Halleck F; Department of Nephrology, Charité University Medicine Berlin, Berlin, Germany.
  • Pruß A; Universitary Tissue Bank, Charité University Medicine Berlin, Berlin, Germany.
  • Schönemann C; Center for Tumor Medicine, H&I Laboratory, Charité University Medicine Berlin, Berlin, Germany.
  • Spierings E; UMC Utrecht, Laboratory of Translational Immunology, Utrecht, The Netherlands.
  • Staeck O; Department of Nephrology, Charité University Medicine Berlin, Berlin, Germany.
Am J Transplant ; 18(2): 523-524, 2018 02.
Article in En | MEDLINE | ID: mdl-28992384
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Histocompatibility Testing / Epitopes Type of study: Prognostic_studies / Risk_factors_studies Language: En Year: 2018 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Histocompatibility Testing / Epitopes Type of study: Prognostic_studies / Risk_factors_studies Language: En Year: 2018 Type: Article